SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding SpringWorks Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 148 | 2 | 137 | −9 |
| Shares | 63.3M | 12.1K | 66.5M | +3.22M (+5.1%) |
| Value | $1.80B | $344.1K | $1.73B | −$73.1M (−4.1%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Baker Bros. Advisors LP | 1,528,538 | $39.8M | 0.24% |
| Nomura Holdings Inc | 192,337 | $5.00M | 0.05% |
| Peregrine Capital Management LLC | 164,541 | $4.28M | 0.13% |
| M28 Capital Management LP | 109,900 | $2.86M | 2.72% |
| Thrivent Financial for Lutherans | 64,533 | $1.68M | 0.00% |
| Kennedy Capital Management, Inc. | 36,740 | $955.6K | 0.03% |
| Hennion & Walsh Asset Management, Inc. | 25,118 | $653.0K | 0.04% |
| Algert Global LLC | 18,230 | $474.2K | 0.03% |
| Axq Capital, LP | 15,214 | $395.7K | 0.28% |
| SEI Investments Co | 13,583 | $353.3K | 0.00% |
| NinePointTwo Capital | 10,824 | $281.0K | 0.12% |
| DnB Asset Management AS | 10,191 | $265.1K | 0.00% |
| SG Americas Securities, LLC | 5,403 | $141.0K | 0.00% |
| Belpointe Asset Management LLC | 3,000 | $78.0K | 0.00% |
| Park Place Capital Corp | 24 | $1.00K | 0.00% |
| GWM Advisors LLC | 18 | $468 | 0.00% |
Sold out (25)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (2)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Jefferies Group LLC | 12,060 | $344.1K |
| Wipfli Financial Advisors LLC, | 13 | $0 |